Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Review
December 01, 2014
JTCB. 2014 Dec 1; 12 (3) : 137-146

Biomarkers in Amyotrofic lateral sclerosis disease

1 Uludağ üniversitesi Tıp Fakültesi, Tıbbi Biyokimya, BURSA, Türkiye

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal disorder of motor neuron degeneration with unclear etiology and no effective treatment to date. The cause of the most cases of ALS remains unknown. Research in ALS has been stimulated by a series of genetic and molecular pathology discoveries. ALS is believed to be a multifactorial and multi-system) disease. There is an intense need to establish biomarkers sensitive to diagnosis, prognostic stratification and disease activity of ALS. Based on this review, we mentioned about some biological markers according to the genetic and molecular pathology reports; in future studies these all may guide us.

Citation

Özmen, Sevda Ünallı, and Yeşim Özarda. 2014. “Biomarkers in Amyotrofic Lateral Sclerosis Disease”. Journal of Turkish Clinical Biochemistry 12 (3):137-46. https://turkclinbiochem.org/index.php/pub/article/view/212.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.